Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Written in Blood

Research from recent issues of Blood
Leniolisib Improves Markers of Immune Dysregulation and Deficiency in Activated PI3Kδ Syndrome
Clonal Hematopoiesis Linked to Secondary Vascular Events, Death in Ischemic Stroke
HU May Lower Malaria Incidence in Children With Sickle Cell Anemia
Valemetostat Performs Well in Tough ATL Cases
CAR T-Cell Therapy May Help Mitigate Disparities in Pediatric ALL
MRD Dynamics Offer Valuable Prognostication During Ixazomib Maintenance for MM
Heavily Pre-Treated Patients With MM Respond to Cilta-Cel CAR T-Cell Therapy
HCT Improves Blood Dynamics, Protects Against Stroke in Children With SCD
Vemurafenib Retreatment Deemed Effective in R/R Hairy Cell Leukemia
Pathogenic Germline Variants Seen in Older Patients With MDS More Frequently Than Expected
Pregnancy Does Not Increase Risk of Severe Bleeding in ITP
Second-Line Axi-Cel Is Cost-Effective in Relapsed/Refractory DLBCL
Patient Race Linked to Relapse Risk and Rituximab Response in iTTP
Radiotherapy Continues to Demonstrate Value in Pediatric cHL
Comparative Analysis Shows Axi-Cel Durable Treatment Benefit in R/R FL
HCT and GT Show Similar Outcomes for ADA-SCID in the Contemporary Era
Prophylactic TXA Does Not Prevent Bleeding in Thrombocytopenia From Hematologic Malignancy Treatment
Certain PTCL Subtypes Benefit More From Etoposide, AHCT
Rivaroxaban Possible Alternative to Heparin for VTE Prophylaxis After Laparoscopic Surgery for Colorectal Cancer
Azacitidine and Decitabine Garner Comparable Clinical Outcomes Among Older, Unfit Patients With AML

Advertisement

Connect with us:

CURRENT ISSUE
Mid-January 2023

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright ©2023 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement